Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
40,750
Frequently Asked Questions
What is Market Cap of Aurobindo Pharma Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aurobindo Pharma Ltd. market cap is 606.3B.
What is the 52-week high for Aurobindo Pharma Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aurobindo Pharma Ltd. 52 week high is 1,592.00 as of September 10, 2025.
What is the 52-week low for Aurobindo Pharma Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aurobindo Pharma Ltd. 52 week low is 1,010.00 as of September 10, 2025.
What is Aurobindo Pharma Ltd. stock price today?
Aurobindo Pharma Ltd. stock price today is 1,048.20.
What was Aurobindo Pharma Ltd. stock price yesterday?
Aurobindo Pharma Ltd. stock price yesterday was 1,041.90.
What is the PE ratio of Aurobindo Pharma Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aurobindo Pharma Ltd.’s P/E ratio is 17.88.
What is the Price-to-Book ratio of Aurobindo Pharma Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aurobindo Pharma Ltd. P/B ratio is 1.8568.
What is the 50-day moving average of Aurobindo Pharma Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aurobindo Pharma Ltd. 50-day moving average is 1,097.08.
How many employess does Aurobindo Pharma Ltd. has?